28
Participants
Start Date
January 30, 2019
Primary Completion Date
April 6, 2019
Study Completion Date
April 6, 2019
30 mg estetrol (E4)
All subjects received both Treatment A and Treatment B either at the first treatment period (Period 1) or at the second treatment period (Period 2). Approximately half of the subjects was randomized to receive either Treatment A followed by Treatment B (sequence AB), or Treatment B followed by Treatment A (sequence BA).
MC Comac Medical Ltd., Sofia
Lead Sponsor
Donesta Bioscience
INDUSTRY